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A defective dNTP pool hinders DNA replication in cell
cycle-reactivated terminally differentiated muscle cells
Deborah Pajalunga*,1, Elisa Franzolin2, Martina Stevanoni2, Sara Zribi1, Nunzia Passaro1, Aymone Gurtner3, Samantha Donsante1,
Daniela Loffredo1, Lidia Losanno1, Vera Bianchi2, Antonella Russo2,4, Chiara Rampazzo*,2 and Marco Crescenzi*,1
Terminally differentiated cells are defined by their inability to proliferate. When forced to re-enter the cell cycle, they generally
cannot undergo long-term replication. Our previous work with myotubes has shown that these cells fail to proliferate because of
their intrinsic inability to complete DNA replication. Moreover, we have reported pronounced modifications of deoxynucleotide
metabolism during myogenesis. Here we investigate the causes of incomplete DNA duplication in cell cycle-reactivated myotubes
(rMt). We find that rMt possess extremely low levels of thymidine triphosphate (dTTP), resulting in very slow replication fork rates.
Exogenous administration of thymidine or forced expression of thymidine kinase increases deoxynucleotide availability, allowing
extended and faster DNA replication. Inadequate dTTP levels are caused by selective, differentiation-dependent, cell cycle-
resistant suppression of genes encoding critical synthetic enzymes, chief among which is thymidine kinase 1. We conclude that
lack of dTTP is at least partially responsible for the inability of myotubes to proliferate and speculate that it constitutes an
emergency barrier against unwarranted DNA replication in terminally differentiated cells.
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Terminal differentiation is commonly defined as a state in
which cells have permanently lost their ability to divide, while
acquiring specialized properties. However, this definition is
merely operational and, despite decades of study, the
mechanisms that keep terminally differentiated cells tena-
ciously arrested are insufficiently understood. Indeed, the
long-sought goal of reactivating terminally differentiated cells
to proliferation is still elusive, despite its great potential in
regenerative medicine.1
Skeletal muscle myotubes constitute an excellent model
system for terminal differentiation and have long been
studied2,3 in a still ongoing effort to induce their proliferation.
The achievement of proliferative reactivation of myotubes has
been repeatedly claimed but found to be scarcely reproduci-
ble. Even the best methods devised so far4 display very low
efficiency and their molecular mechanisms await elucidation.
Reactivation of the cell cycle inmyotubes can be achieved by
a variety of means, including infection with oncogenic
viruses,2,3,5 forced expression of cell cycle genes6 or
oncogenes,7 removal of cell cycle inhibitors (CKIs),8 loss of
tumor suppressors such as pRb,9 and induction of abortive
apoptosis.4 Irrespective of the triggering stimulus, cell cycle
re-entry does not lead to widespread, sustained proliferation
of myotube-derived cells. Rather, it generally results in
apoptosis,10 G2-phase arrest,
6 and/or mitotic catastrophe,11
depending on the specific methods adopted to initiate the cell
cycle. These heterogeneous outcomes might originate from a
common cause; however reactivated, myotubes cannot
complete DNA synthesis and suffer DNA damage. Interestingly,
other non-proliferating cells (e.g., quiescent or senescent),
reactivated by the samemeans used to forcemyotubes into the
cell cycle, undergo complete DNA replication and proliferate
extensively. Thus, deficient DNA duplication is intrinsic to
myotubes and not due to the reactivating conditions.11We have
argued that defective DNA duplication and DNA damage occur
in most terminally differentiated cell types upon reactivation.11
In this view, terminal differentiation entails critical, characteristic
traits that hinder DNA replication and, hence, cell proliferation.
The cellular concentrations of DNA precursors, the deox-
ynucleoside triphosphates (dNTPs) are set by the balance
between synthesis via two anabolic pathways, degradation by
catabolic enzymes, and consumption by DNA polymerases.
The anabolic pathways comprise de novo synthesis by
ribonucleotide reductase (RNR), converting ribonucleoside
diphosphates to the corresponding deoxynucleotides, and the
salvage pathways, which phosphorylate deoxynucleosides.
The dNTP pool varies in size according to the functional
state of the cell.12–14 It expands through the upregulation of
key synthetic enzymes shortly before S phase, when the need
for dNTPs becomes high.13–16 During quiescence, whether
permanent or reversible, dNTPs are needed only for mito-
chondrial replication and DNA repair, and the dNTP pool is
small.16 Myotubes conform to this rule and contain small
amounts of dNTPs.17 We hypothesized that incomplete DNA
replication and DNA damage in rMt might stem, at least
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partially, from a failure to expand properly the dNTP pool upon
cell cycle re-entry.
Here we show that in rMt the concentration of dNTPs
increases relative to control myotubes but in a highly
unbalanced manner, with deoxythymidine and deoxyguano-
sine triphosphates (dTTPand dGTP) remaining at the very low
levels associated with non-proliferation. Restoration of dNTP
levels closer to those of proliferating myoblasts extends DNA
replication and reduces DNA damage in rMt. Low dTTP and
dGTP levels are due to persistent downregulation of genes
encoding key dTTP synthetic enzymes, prominent among
which is thymidine kinase 1 (TK1). Such genes appear to be
permanently downregulated during terminal differentiation of
myotubes and unresponsive to cell cycle reactivation. Our
results unveil one mechanism through which permanent
proliferation arrest is ensured in postmitotic muscle cells.
Results
Atypical response of the myotube dNTP pools to cell
cycle reactivation. To determine whether deoxynucleotide
scarcity is responsible for incomplete DNA replication in rMt,
dNTP levels were dynamically measured in proliferating
murine myoblasts and in myotubes, either resting or
reactivated by RNAi to the p21 and p27 CKIs8 (Figure 1
and Supplementary Table S1). In these experiments,
reactivation efficiency was about 30–40%, evaluated as the
percentage of cells double-positive for 5-bromo-2′-deoxyur-
idine (BrdU) incorporation into DNA and muscle-specific
myosin heavy chain (data not shown). rMt (Figure 1, Mt
p21p27i) were analyzed at different time points encompass-
ing S phase. Proliferating myoblasts (Prol Mb) displayed a
typical balance among the dNTPs, with dTTP as the largest
and dGTP as the smallest pool,13 while resting myotubes
(Mt CTRi) showed the expected low levels of all four
dNTPs.17 Surprisingly, rMt showed amounts of deoxycytidine
and deoxyadenosine triphosphate (dCTP and dATP, respec-
tively) markedly exceeding those found in proliferating
myoblasts. In striking contrast, dTTP and dGTP concentra-
tions were almost unchanged, compared with those of resting
myotubes, remaining well below those of proliferating
myoblasts (Figure 1 and Supplementary Table S1). For
comparison, myoblasts rendered quiescent in suspension
culture (Q)18 showed the expected low levels of all four
dNTPs.12 When these cells were reactivated (rQ) by re-
establishing substrate adhesion, the dNTP pools promptly
returned to proliferation levels.
dNTP pool complementation extends DNA synthesis in
reactivated myotubes. As rMT perform only incomplete
DNA replication, we asked whether restoring proliferation-like
levels of dTTP and dGTP would extend DNA synthesis.
In initial experiments, we attempted to increase dNTP
concentrations by silencing SAMHD1, a key dNTP catabolic
enzyme that coordinates the dNTP pool with the cell cycle.19
Immunoblotting demonstrated a fairly efficient knockdown,
resulting in higher levels of dCTP (Supplementary Figure S1).
However, the other three dNTPs were left unchanged, in
contrast to what observed in other cell types.19,20 The lack of
effect of SAMHD1 depletion on the dTTP and dGTP pools
suggests that their shortage in myotubes is determined by
deficient synthesis, rather than high catabolism.
In an alternative strategy to remodel the dNTP pool,
myotubes reactivated by CKI suppression were cultured in
the presence of 500 μM deoxyguanosine (GdR) and/or
100 μM thymidine (TdR) and compared with control rMt.
These concentrations were determined empirically (see
Materials and Methods section). We observed that early
treatment with deoxynucleosides inhibited S-phase entry of
rMt and found that the optimal time for addition was 17 h from
the start of siRNA transfection, close to the beginning of S
phase (around 24 h). Figure 2a and Supplementary Table S2
show that exogenous addition of GdR+TdR or TdR alone
increased both dGTP and dTTP, whereas the sole provision of
GdR exclusively raised dGTP levels.
The extent of DNA replication was quantitated under all of
the above conditions. As multinucleated myotubes are
scarcely amenable to cytofluorimetric analyses, we resorted
to in situ microfluorimetric measurements of DNA content in
individual nuclei, as reflected by 4′,6-diamidino-2-phenylin-
dole dilactate (DAPI) fluorescence intensity. Myotubes reacti-
vated by p21 and p27 RNAi (Figure 2b and Supplementary
Table S3, p21p27i) displayed a modest increase in DNA
content (27%above controls, Supplementary Table S3, CTRi).
Strikingly, treatment with GdR+TdR significantly extended
DNA synthesis (DNA content 52% above controls,
Supplementary Table S3, p21p27i GdR+TdR).
To investigate the individual contribution of the two
deoxynucleosides, we treated rMt with either GdR or TdR.
Administration of GdR, consistent with its inability to increase
dTTP levels, did not meaningfully increase DNA synthesis in
rMt (Figure 2c; andSupplementary Table S3, p21p27i GdR). In
contrast, treatment with TdR alone, which raised both dTTP
and dGTP levels, increased rMt DNA content to 56% above
control myotubes, mimicking the combined action of GdR
+TdR (Figure 2c; Supplementary Table S3, p21p27i TdR).
Figure 1 Reactivated myotubes possess low levels of dTTP and dGTP. Myotubes
were transfected with siRNAs to p21 and p27 (Mt p21p27i) or to GFP as a control (Mt
CTRi) and harvested at the indicated times from the beginning of treatment (Hrs fbt).
Reference samples include proliferating myoblasts (Prol Mb), myoblasts cultured in
suspension to attain quiescence (Q), and formerly quiescent myoblasts reactivated by
replating (rQ). The dNTP pool was extracted with 60% methanol and individual
dNTPs quantitated by a DNA polymerase-based assay. The data are expressed as
pmoles of deoxynucleotide per absorbance unit (AU) at 260 nm (see Materials and
Methods section). The results are shown as averages±S.E.M. of the indicated
numbers (n) of independent experiments
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Thus administration of TdR alone is sufficient to double the
extent of DNA replication in rMt.
We investigated whether improved DNA replication reduces
the DNA damage that accompanies incomplete genome
duplication in rMt.11 To this aim, we performed microfluori-
metry for γ-H2AX, a marker of double-strand DNA breaks, in
rMt with or without addition of GdR+TdR. Deoxynucleoside
administration caused a significant reduction (36.9%± 4.7,
Figure 2 Higher dTTP and dGTP levels allow extended DNA replication in reactivated myotubes. (a) Myotubes reactivated by p21 and p27 RNAi as in Figure 1. GdR (500 μM)
and/or TdR (100 μM) were added to the culture medium 17 h later. The dNTP pool was quantitated as in panel (a) 30 h from the beginning of treatment (fbt); data from 2–4
independent experiments and statistical evaluations are shown in Supplementary Table S2. Values for proliferating myoblasts and myotubes reactivated by p21 and p27 RNAi (30 h
fbt) are the same shown in Figure 1 and are reproduced here for ease of reference. (b and c) Myotubes were transfected as in panel (a); 30 h fbt, at the end of S phase, the cells
were immunostained for MCM7, a marker of cell cycle reactivation, and counterstained with DAPI. Nuclear DNA content was evaluated by microfluorimetric measurement of DAPI
fluorescence in individual MCM7+ myotube nuclei. On average, 209 nuclei per sample were evaluated (range 112–285) and their DNA content distribution is shown by the
corresponding curve. Nuclei belonging to control, resting myotubes were uniformly MCM7− and their DNA content was determined without selection. The graphs refer to 1
representative experiment out of 2–4; Supplementary Table S3 summarizes all the results. (d) Myotubes, treated as indicated, were subjected, 30 h fbt, to immunofluorescence for
γ-H2AX and Ki67, a marker of cell cycle reactivation. γ-H2AX staining intensities were measured in Ki67-positive nuclei by microfluorimetry. Control myotubes displayed no
detectable γ-H2AX fluorescence and are not reported in the graph. (e) Myotubes were infected with an E1A-expressing adenovirus (Ad-E1A) or a control one (Ad-CTR). At the end
of S phase, 39 h postinfection, microfluorimetric quantitation of DNA content was performed as in panel (b). The graph reports one out of the three experiments; Supplementary
Table S3 summarizes all the results. (f) dNTP measurements in myotubes reactivated by E1A or infected with Ad-CTR. The myotubes were harvested at the indicated times
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n= 2, Po0.000001 by Kolmogorov–Smirnov) in γ-H2AX
staining (Figure 2d and Supplementary Figure S2), indicating
that at least part of the damage incurred by rMt is due to
deoxynucleotide shortage.
One other means to induce myotubes into the cell cycle is
through expression of the adenovirus E1A oncogene.5
Microfluorimetry (Figure 2e) showed that E1A expression
attains duplication of a higher proportion of the genome,
compared with p21 and p27 suppression (average DNA
content 49 versus 27% above controls, respectively,
Supplementary Table S3). dNTP pool measurements revealed
that E1A generates somewhat higher levels of both dGTP and
dTTP (Figure 2f) than reactivation induced by CKI depletion
(Figure 2a, Mt p21p27i). Altogether, these results lead to the
conclusion that the dNTP pool limits the extent of DNA
replication in rMt.
Slow replication fork rate in reactivated myotubes is
partially rescued by dNTP complementation. To explore
the dynamics of DNA replication in rMt, we performed DNA
combing analyses of myotubes reactivated by CKI depletion in
the presence or absence of deoxynucleoside treatment,
compared with proliferating myoblasts. As illustrated in
Figures 3a and b, the replication fork rate of rMt was extremely
low, less than one-sixth of that measured in proliferating
myoblasts (median 0.35 versus 2.33 kb/min, respectively,
Supplementary Table S4), mimicking the effect of replication
stress conditions.21 Addition of GdR+TdR partially rescued
replication fork rate, bringing it to 0.91 kb/min, nearly half of that
of myoblasts. This result suggests that poor DNA replication in
myotubes is primarily a result of the lack of building blocks.
Myoblasts and rMt supplementedwith deoxynucleosides had
comparable values of total DNA fiber length (median 1052.0
versus 996.6 kb, respectively, as shown by DNA counter-
staining; Supplementary Table S5). In contrast, unsupplemen-
ted rMt displayed significantly reduced fiber length (median
488.1 kb; Po0.01 Kruskal–Wallis test; Supplementary
Table S5). This observation suggests an intrinsic DNA fragility,
consistentwith the high prevalence ofDNAbreaks in these cells
(Figure 2d and Pajalunga et al.11). The shorter fiber length
prevented the measurement of some parameters in unsupple-
mented rMt (Supplementary Table S4).
Consistent with the reduction in fork rates, the average
distance between activated replication origins was signifi-
cantly reduced in rMt dosedwith deoxynucleosides, compared
with proliferating myoblasts (median inter-origin distance
113.4 versus 154.8 kb; Figure 3c). This result fits the notion
that, during replication stress, additional, otherwise inactive
origins fire to fill in replication gaps.22,23 Smaller replication
clusters are observed in deoxynucleoside-treated rMt than in
myoblasts (Figure 3d).
The proportion of unidirectional forks in deoxynucleoside-
treated rMt was increased, in comparison with myoblasts, with
slight statistical significance (0.05oPo0.01, chi-square test;
Supplementary Table S4). However, this parameter, in both
cell types, fell within the ranges determined in other
mammalian cell lines.24 No differences were observed when
paused/arrested forks and asynchronous patterns were
compared in deoxynucleoside-dosed rMt and myoblasts
(Supplementary Table S4).
Taken together, these results suggest that the main
consequence of the deficiency of dNTPs in rMt is a
pronounced reduction in fork rate, which is indeed partly
rescued by the addition of deoxynucleosides.
Key enzymes in thymidine nucleotide synthesis are
downregulated in reactivated myotubes. To understand
the genesis of the relative lack of dTTP and dGTP in rMt, we
explored the expression of a number of enzymes involved in
their synthesis. For this purpose, RNA extracted from prolife-
rating myoblasts, control myotubes, or rMt was analyzed by
quantitative, real-time PCR (qPCR). Figure 4a shows that, as
expected of non-proliferating cells, postmitotic myotubes
replace the ribonucleotide reductase R2 subunit with
p53R2.25 In agreement with our previous results,17 at least
three enzymes involved in thymidine nucleotide synthesis
(dCMP deaminase (DCTD); thymidylate synthase (TS); TK1)
were strongly downregulated in resting myotubes. Their
expression barely rose upon cell cycle re-entry, suggesting
an explanation for the low levels of dTTP found in CKI-
suppressed rMt. The concomitant lack of dGTP in reactivated
myotubes reflects the scarcity of dTTP that is the allosteric
effector of GDP reduction by ribonucleotide reductase.26
Compared with CKI-suppressed rMt, myotubes reactivated
by E1A displayed somewhat higher expression of DCTD, TS,
and TK1 (1.9, 1.5, and 3.9-fold, respectively; Figures 4a
and b), in keeping with their higher levels of dTTP (Figure 2f).
As a control, quiescent myoblasts displayed a shallower
downregulation of the dTTP synthesis enzymes and, upon cell
cycle reactivation, promptly returned to an expression pattern
typical of proliferating cells (Figure 4c).
Altogether, these results indicate that low expression of
specific biosynthetic enzymes is responsible for the limiting
amount of dTTP in rMt.
DNA synthesis in reactivated myotubes critically
depends on thymidine kinase activity. To determine
whether the inadequate synthesis of dTTP in rMt is indeed
due to low anabolism, we increased thymidine kinase activity.
Myotubes reactivated by p21 and p27 knockdown were
infected with a recombinant adenovirus carrying herpes
simplex thymidine kinase (Ad-TK) or a control virus. In
keeping with the qPCR results, TK1 activity was extremely
low in postmitotic myotubes (Mt CTRi and Mt Ad-Ctr in
Figure 5a) and only moderately increased in control-infected,
CKI-suppressed rMt (Mt p21p27i Ad-CTR). Conversely,
Ad-TK-infected myotubes showed very high TK activity,
independent of cell cycle reactivation (Figure 5a, Mt Ad-TK
and Mt p21p27i Ad-TK).
Ad-TK muscle cells exhibited extremely high levels of dTTP,
irrespective of cell cycle re-entry (Figure 5b). Interestingly,
they also showed a marked increase in dGTP, attributable to
the stimulatory allosteric action of dTTP on GDP reduction by
RNR.26 Despite the high concentrations of dTTP, myotubes
infected with Ad-TK were reactivated by CKI suppression just
as efficiently as the control-infected ones (data not shown).
As expected, control-infected rMt displayed limited DNA
replication (Figure 5c and Supplementary Table S6). In
contrast, in rMt forcibly expressing TK, DNA synthesis was
dramatically extended, though not reaching completion.
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To assess whether the low levels of TK1 contribute to dNTP
pool synthesis and DNA replication in rMt, we silenced
TK1 in myotubes reactivated by CKI-depletion (Figure 6). In
the absence of suitable antibodies against themurine enzyme,
we resorted to a functional assay to demonstrate the efficacy
of TK1 knockdown. Figure 6a shows that 5-ethynyl-2′-
deoxyuridine (EdU) incorporation into rMt largely depends
on TK1 expression, as low as it might be in these cells.
Myotubes were similarly reactivated by CKI suppression,
independently of TK1 interference, as shown by the expres-
sion of the cell cycle-dependent protein MCM7. However, in
TK1-knockdown cells, EdU incorporation was nearly unde-
tectable, as its conversion into EdUTP was severely impaired.
TK1 knockdown markedly reduced DNA replication in
myotubes reactivated by CKI RNAi (Figure 6b and Table 1),
confirming that TK1 activity, albeit low (Figure 5a), was limiting
for DNA synthesis in rMt. In contrast, suppression of DCTD,
which concurs to convert deoxycytidine monophosphate into
thymidine monophosphate (see later, Figure 8b), had no effect
on DNA replication (Table 1).
Similar experiments were carried out with myotubes
reactivated by E1A expression. In these cells, TK1 RNAi
Figure 3 Molecular combing shows that low dNTP levels deeply affect fork rates in reactivated myotubes. (a) Fork rate distributions evaluated by molecular combing in
proliferating myoblasts and in myotubes reactivated as indicated. The samples are highly statistically different (Po0.001, Kruskal–Wallis non-parametric test). (b) Representative
replication forks for the three samples evaluated. Images are not in the same scale, due to the large differences in fork rates (calibration bar= 100 kb). Green and red fluorescent
tracks correspond to the first and second pulse (IdU and CldU, respectively), whose duration was modulated according to the average replication fork rate (30 min+30 min for Prol
Mb and Mt p21p27i GdR+TdR; 60 min+60 min for Mt p21p27i). DNA is counterstained by immunodetection (blue fluorescence). Black arrows indicate origin positions. To
appreciate fork rate differences among the three samples, the ideogram of a replication fork running at 1 kb/min is drawn above each microscope image. (c) Inter-origin distance
distributions in proliferating myoblasts and rMt. The samples are highly statistically different (Po0.001, Kruskal–Wallis non-parametric test). (d) Length distributions of replication
clusters in proliferating myoblasts and rMt. The samples are highly statistically different (Po0.001, Kruskal–Wallis non-parametric test). (e) Representative replicating molecules
from myoblasts and reactivated myotubes. Fluorescence as described for panel (b). White arrows indicate the positions of bidirectional replication origins. unidir, unidirectional
forks; nc, not classified. Calibration bar= 200 kb
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reduced DNA replication, though less markedly than in CKI-
suppressed cells (Table 1). Presumably, this result reflects the
upregulation of other dNTP synthetic enzymes in E1A-
reactivated myotubes (Figure 4). Indeed, in these cells,
suppression of DCTD did reduce DNA replication (Table 1).
In agreement, double suppression of TK1 and DCTD resulted
in an even stronger limitation of DNA synthesis.
Altogether, these results show that the low expression of
enzymes involved in dTTP anabolism is responsible for low
DNA precursor levels and confirm that expanding the dNTP
pool increases DNA synthesis.
The TK1 gene is deeply downregulated in myotubes and
unresponsive to cell cycle re-entry. TK1 is a cell cycle-
dependent gene, whose transcription is strongly downregulated
in non-proliferating cells and sharply increases at the G1/S
boundary upon cell cycle re-entry.27,28 Myotubes, however
reactivated, upregulate most cell cycle-related genes (Camarda
et al.;29 Figures 4a and b; and our unpublished global gene
expression data). Thus it is remarkable that, in CKI-depleted
rMt, the expression of TK1 and a few other dNTP synthetic
enzymes is held tightly down.
To explore the causes of this distinct behavior, we
investigated the epigenetic regulation of TK1 and, as controls,
some other genes differentially regulated in myoblasts and
myotubes. Figure 7a shows that Cyclin A2 is silenced in
Figure 4 Thymidine synthetic enzymes are not upregulated in reactivated
myotubes. (a) Myotubes were reactivated by p21 and p27 depletion (Mt p21p27i) or
(b) E1A expression (Mt Ad-E1A). The mRNA levels of several dNTP synthetic
enzymes were quantitated by qPCR in myotubes treated as indicated, proliferating
myoblasts, and (c) quiescent myoblasts (Q) or myoblasts reactivated after
quiescence (rQ). In all cases, reactivated cells were harvested in the midst of S
phase. Histograms show fold increases in comparison with proliferating myoblasts,
made equal to 1 (dashed lines) (averages±S.E.M. of two independent experiments).
R1, R2, and p53R2 indicate the corresponding ribonucleotide reductase subunits;
DCTD, deoxycytidine monophosphate deaminase; dGK, deoxyguanosine kinase;
TK1 and TK2, thymidine kinases 1 and 2; TS, thymidylate synthase Figure 5 Exogenous thymidine kinase expression increases dTTP and dGTP
levels and extends DNA synthesis in reactivated myotubes. (a) Total TK activity in
myoblasts or myotubes, treated as indicated and collected 30 h from the beginning of
treatment (fbt). The scale is logarithmic to accommodate widely different values.
(b) dNTP pools measured at the indicated times in myoblasts or myotubes treated as
shown. Logarithmic scale. (c) Microfluorimetric measurements of DNA content in the
indicated cell samples, harvested 30 h fbt. The graph refers to one of the two
experiments; Supplementary Table S6 summarizes all the results. Ad-CTR, infection
with control adenovirus; Ad-TK, infection with the adenovirus expressing herpes
simplex virus TK; CTRi, interference with control siRNA
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postmitotic myotubes but is upregulated in rMt, consistent with
its crucial role in the cell cycle. In contrast, Pax7, a muscle-
specification transcription factor, is expressed in myoblasts,
silenced in myotubes, and not reactivated in rMt. Finally, the
muscle differentiation factor Myogenin is not expressed in
myoblasts but is present in myotubes, irrespective of their cell
cycle status.
Chromatin immunoprecipitations (ChIPs) were carried out
for acetylated lysine 9 of histone H3 (H3K9Ac), a marker
associated with actively transcribed chromatin.30 H3K9Ac
enrichment at gene promoters closely reflected the expression
of each gene in the various cell types and conditions
(Figure 7b). In particular, it was highly enriched at the TK1
promoter in myoblasts, but scarcely so in myotubes, and even
less present in rMt. This result indicates that the TK1
regulatory region is transcriptionally active in myoblasts but
adopts a repressed state in myotubes. Different from Cyclin
A2, whose promoter is reactivated upon re-entry into the cell
cycle (Figure 7b), the TK1 gene remains inactive even after
myotube reactivation.
Unlike that of TK1, the expression of the RNR subunit R2
increases in response to myotube reactivation. Indeed,
H3K9Ac, though markedly reduced at the R2 promoter in
myotubes compared with myoblasts, promptly raises upon cell
cycle re-entry (Supplementary Figure S3A), underscoring the
differential regulation of these key metabolic enzymes.
Figure 6 Suppression of TK1 impairs DNA replication in reactivated myotubes. (a) Double immunofluorescence for MCM7 and EdU in p21p27-depleted myotubes,
additionally subjected to interference with TK1 or control siRNA. Cultures were fixed during S phase and stained as indicated. PhC, phase contrast. Bar, 50 μm.
(b) Microfluorimetric measurements of DNA content in the indicated cell samples, assayed 31 h after the beginning of treatment
Table 1 DNA replication in reactivated myotubes: role of TK1 and DCTD
RNAi CTR p21p27, CTR p21p27, TK1 p21p27, DCTD Comparison
DNA content (% increase42n) 0 26.6 7.6 31.5
P (Kolmogorov–Smirnov) o0.000001 NS p21p27, CTR
Infection Ad-CTR Ad-E1A Ad-E1A Ad-E1A Ad-E1A
RNAi — CTR TK1 DCTD TK1, DCTD
DNA content (% increase42n) 0 43.8 27.5 36.3 16.6
P (Kolmogorov–Smirnov) o0.000001 o0.0054 o0.000001 Ad-E1A, CTR
Abbreviation: NS, not significant
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ChIPs for total RNA polymerase II and for its active form,
phosphorylated on CTD-repeat Ser5,31 closely paralleled the
above results (Figure 7c and Supplementary Figure S3B),
indicating substantial transcription only from promoters
heavily marked with H3K9Ac.
These data indicate that TK1 is a rare cell cycle-regulated
gene permanently downregulated during skeletal muscle
differentiation and mechanistically explain the inability of
myotubes to properly expand the dNTP pool in response to
cell cycle reactivation.
Discussion
This paper investigates the causes of incomplete DNA
synthesis in cell cycle-reactivated myotubes.11 We show that
the dNTP pool of rMt is highly imbalanced and limits DNA
synthesis. The structure of the enzyme network regulating
dNTP concentrations13 is altered. Although cell-cycle reacti-
vation restores the S-phase-specific transcription of RNR,
insufficient expression of genes encoding key dTMP synthetic
enzymes, notably TK1, drastically hampers the production of
dTTP (Figure 8a).
The demonstration that some genes required for cell
proliferation, different from most others, are permanently
downregulated in myotubes (Camarda et al.;29 Figures 4a
and b; and our unpublished data) explains in part the inability
of these cells to fully replicate DNA upon cell cycle reactiva-
tion. This mechanism might constitute a safeguard against
unwarranted mitotic activity and explains in part the extreme
difficulties encountered in inducing terminally differentiated
muscle cells to proliferate.
DNA combing analyses have shown that the preponderant
DNA duplication defect in rMt is a dramatic 85% reduction in
replication fork rate (Figure 3a and Supplementary Table S4).
The most parsimonious interpretation of this result is that such
low replication speed is caused by an inadequate supply of
deoxynucleotides. Restoration of sufficient dNTP levels nearly
triples fork speed, which nonetheless remains significantly
reduced, compared with that of myoblasts. These findings
further illustrate the need to search for other mechanisms that
impede myotube proliferation.
In rMt, DNA replication is limited by low levels of dTTP and
possibly dGTP. Indeed, any experimental intervention that
raises both pools results in extended DNA synthesis, whereas
increasing solely dGTP is ineffective. When cells are
incubated with TdR, the concentrations of dGTP and dTTP
rise jointly, as dTTP induces GDP reduction by RNR.26 The
pathway converting dCMP to dTMP (Figure 8b) is virtually
inactive in myotubes, as shown by the observation that DCTD
knockdown does not affect DNA replication in rMt (Table 1).
Such inactivity causes accumulation of dCTP and lack of
dTTP, which is not available for its twofold function as DNA
precursor and allosteric stimulator of GDP reduction.
TK1, albeit limiting in rMt, has a crucial role in dTTP
synthesis, as demonstrated by the reduction in DNA replica-
tion caused by its silencing (Table 1). TK1 and other genes
involved in dTTP synthesis are upregulated somewhat more in
myotubes reactivated by E1A expression (Figure 4b) than in
CKI-depleted ones. Accordingly, the former duplicate their
DNA more extensively (Figure 2e), probably reflecting the fact
that adenovirus E1A has evolved as an efficient S-phase
inducer, to allow viral replication in host cells.
Figure 7 The TK1 locus is strongly repressed in terminally differentiated myotubes and is not reactivated by cell cycle re-entry. (a) Western blotting analyses of the indicated
proteins in the cells shown. Reactivated myotubes were harvested in middle S phase. β-Tubulin is the loading control. n.s., non-specific band. (b) ChIP-measured enrichment in
H3K9Ac at the indicated promoters in the cells shown. rMt were collected in middle S phase (average± S.E.M. of≥ 2 independent experiments). (c) ChIP-measured enrichment
in total RNA polymerase II (Pol II) and active Pol II (Pol II pS5) at the same promoters as in panel (b) (average± S.E.M. of three replicas)
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Our results show that the dTTP synthetic pathways are
controlled in a selective and especially stringent manner in
postmitotic muscle cells. It is worth noting that herpes simplex
virus type I, whose natural host is the neuron, carries its own
ribonucleotide reductase- and TK-encoding genes.32 This
suggests that persistent TK silencing is a feature that char-
acterizes other terminally differentiated cell types, besides
myotubes.
To conclude, we propose a model whereby DNA synthesis
in rMt is severely limited by the lack of DNA precursors,
resulting from the coordinated, reactivation-resistant silencing
of genes involved in dTTP synthesis. This unexpectedly tight
control might serve to prevent undue proliferative activity in
myotubes. In this respect, we note that at least one natural
condition induces re-entry into the cell cycle of muscle nuclei,
namely infection by Trichinella spiralis.33
Materials and Methods
Cells and adenoviruses. Muscle satellite cells were isolated following a
previously described protocol,34 with minor modifications. Briefly, hindlimbs were
removed from 3-week-old mice, and the muscle mass was minced using scissors.
Cells were enzymatically dissociated by a 30 min incubation in 0.1 mg/ml
collagenase/dispase solution (Roche, Basel, Switzerland), followed by a 45 min
digestion in 1 mg/ml collagenase solution (Sigma Aldrich, St. Louis, MO, USA),
pipetting several times. When tissue suspension no longer showed visible clumps,
the homogenate was filtered through a 70 μm nylon mesh cell strainer (Becton
Dickinson, East Rutherford, NJ, USA). Cells were collected by centrifugation and
plated on gelatin-coated dishes in growth medium (GM): Ham’s F-10 medium (Life
Technologies, Carlsbad, CA, USA) supplemented with 20% fetal bovine serum
(FBS), 3% chicken embryo extract, and 2.5 ng/ml basic-FGF. Spontaneous
immortalization occurred within 10 passages. Differentiation was induced by plating
cells on gelatin-coated dishes in differentiation medium: Dulbecco’s Modified Eagle
Medium (Life Technologies) supplemented with 10% FBS. After 48 h, the vast
majority of the cells were differentiated (differentiation index 495%).
Satellite cells were made quiescent by culturing them in suspension on semisolid
medium (GM with 0.7% Noble Agar (Life Technologies) for 21 h. Cell cycle re-entry
was triggered by replating them on gelatin-coated dishes in liquid GM.
E1Awas expressed using the dl520 mutant adenovirus previously described.5 This
virus was used at a multiplicity of infection (MOI) of 350. The recombinant adenovirus
expressing herpesvirus thymidine kinase was kindly donated by Dr. Rafael Aldabe
(CIMA, University of Navarra, Navarra, Spain). This virus was used at an MOI 300.
When both infection and RNAi were performed, the latter was achieved 1 h after the
infection.
Gene silencing by siRNA transfection. Myotubes were transfected with
the HiPerFect transfection reagent (Qiagen, Hilden, Germany) combined with
siRNA. siGenome duplex (Dharmacon, Lafayette, CO, USA) siRNAs were used to
interfere with murine CDKN1A (p21) and CDKN1B (p27) transcripts. The antisense
sequences for p21 and p27 were 5′-P.GAACAGGUCGGACAUCACCUU-3′ and 5′-
P.UAUCCCGGCAGUGCUUCUCUU-3′, respectively. The antisense sequence to
mouse SAMHD1 was 5′-AUAGAAGUGAACACGAUCGAT-3′ (Qiagen). Interference
with murine TK1 and DCTD was carried out using Dharmacon siGenome SMART
pools M-042809-00 and M-058063-02, respectively. The siRNA to GFP (antisense
sequence: 5′-GGUGCGCUCCUGGACGUAGCCUU-3′, Sigma Aldrich) was trans-
fected as a control. Transfection complexes were kept in the culture medium
throughout the experiment.
Deoxynucleoside complementation. GdR and TdR (Sigma Aldrich) were
added, singularly or in combination, to rMt culture medium at final concentrations of
500 and 100 μM, respectively, 17 h after siRNA transfection. GdR and TdR
concentrations were chosen on empirical bases, taking into account the instability of
GdR and the potential cell cycle-blocking effects of high levels of TdR. The
concentration ranges considered were 10–100 μM for TdR and 100–500 μM for
GdR. The concentrations selected were the ones restoring myoblast-like levels of
dTTP and dGTP in rMt.
dNTP pool analysis. dNTP pools were extracted from cell cultures with 60%
ice-cold methanol for 1 h. Cells left on the plate were dissolved in 0.3 M NaOH and
the absorbance at 260 nm of the lysates was used as an index of cell mass, in turn
an approximation for cell number.35 dNTP pool quantitations were performed by an
in vitro-modified DNA polymerase-based assay, as described.16 Two different
Figure 8 Graphic summary. (a) Graphical representation of the main results of
this work. The nucleotide pool is adequate and balanced in myoblasts, allowing fast
DNA replication. Upon differentiation into myotubes, muscle cells deeply silence
transcription of a few genes involved in dTTP synthesis, exemplified by TK1.
Accordingly, such genes display markedly reduced histone H3 lysine 9 acetylation
and their products are depleted in myotubes, in spite of cell cycle re-entry. Loss of key
metabolic enzymes leads to a dramatic fall in dTTP and, indirectly, dGTP levels. As a
consequence, cell cycle reactivation in myotubes is marred by slow DNA replication,
accompanied by DNA damage. (b) Synthesis of thymidine triphosphate in
mammalian cells. dTTP synthesis occurs through two pathways: de novo synthesis
by RNR and salvage of TdR. The latter is initiated by two thymidine kinases, cytosolic
TK1, expressed in S phase, and mitochondrial TK2, which is a constitutively
expressed enzyme. During S phase, RNR is composed by homodimers of the R1 and
R2 subunits, whereas in non-dividing or differentiated cells R2 is replaced by p53R2.
De novo-produced thymidine monophosphate (dTMP) derives from deoxyuridine
monophosphate (dUMP) via methylation by TS. In its turn, dUMP derives from (i)
dephosphorylation of dUDP produced by RNR and (ii) deamination of deoxycytidine
monophosphate (dCMP) by DCTD. The latter process prevails in mammalian cells.41
The salvage pathway receives TdR from the intracellular catabolism of dTMP by
5′-nucleotidases (cytosolic cdN and mitochondrial mdN) and of dTTP by the nuclear
dNTP-triphosphohydrolase SAMHD1 or via uptake from the extracellular environ-
ment. In terminally differentiated myotubes DCTD, TS and TK1 are strongly
repressed (barred arrows) and reactivation by p21 and p27 silencing fails to induce
them to levels approaching those of proliferating cells. Thus both pathways
converging on dTMP, an essential precursor of dTTP, are severely impaired in
reactivated myotubes
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aliquots of each pool extract were analyzed and pool sizes were normalized by the
A260 nm of the NaOH lysates.17
Immunofluorescence and western blotting. Immunofluorescence was
performed on cells fixed with 4% formaldehyde and permeabilized with 0.25% Triton
X-100 (Sigma Aldrich). For BrdU staining, DNA was denatured with 2 M
hydrochloric acid. Primary mouse monoclonal antibodies were used to detect:
BrdU (Bu20a clone, DAKO); MCM7 (DCS-141 clone, Santa Cruz, Dallas, TX, USA);
myosin heavy chain ((MF20)36); γ-H2AX (JBW301 clone, Millipore, Billerica, MA,
USA). Ki67 was detected with a rabbit polyclonal antibody (Abcam, Cambridge, UK,
cat. no. AB9260). The modified thymidine analog EdU, incorporated into newly
synthesized DNA, was revealed by the Click-iT Imaging Kit (ThermoFisher
Scientific, Waltham, MA, USA). AlexaFluor 488- or 594-conjugated secondary
antisera to mouse or rabbit IgG (Life Technologies) were used. Nuclei were
counterstained with 0.2 μg/ml DAPI for 20 min.
To prepare total cell extracts, cells were harvested, washed in PBS, and lysed with
RIPA buffer, containing 500 mM NaCl. Proteins were separated on gradient, 4–12%
polyacrylamide gels and analyzed by western blotting with the following antibodies:
anti-SAMHD1 (Abcam, clone 1A1), anti-Cyclin A2 (C-19, Santa Cruz), anti-Pax7
(Developmental Studies Hybridoma Bank, University of Iowa, IA, USA, cat. no. pax7,
RRID:AB_528428), anti-Myogenin (FD5 hybridoma), anti-β-tubulin (2-28-33 clone,
Sigma Aldrich).
DNA quantitation and γ-H2AX expression. Microfluorimetry was used
to quantitate DNA in myotube nuclei stained with DAPI, as multinucleated myotubes
are not readily amenable to cytofluorimetry. rMt were allowed to synthesize DNA
until shortly before M phase or cell death. The cells were then fixed, immunostained
for MCM7 (a cell cycle-dependent marker of reactivation), and counterstained with
DAPI.37 To assess the extent of DNA replication in rMt and exclude non-reactivated
ones, DAPI fluorescence intensity was measured solely in MCM7-positive nuclei.
Control myotubes were subjected to the same treatments, but DAPI microfluorimetry
was performed on all nuclei, which were uniformly MCM7-negative. Random
myotube images were captured at room temperature, using an Axioskop 2 Plus
fluorescence microscope (Carl Zeiss, Oberkochen, Germany) equipped with a
Neofluar 40 × objective (NA 0.75) and an AxioCam camera (Carl Zeiss). Images
were captured with the ZEN 2012 software (Carl Zeiss). The images were analyzed
with the public domain software ImageJ (v. 1.43u). DAPI fluorescence intensity
(proportional to DNA content) was measured in all well-defined individual nuclei in
the captured images, with local background subtraction. Fluorescence values, in
arbitrary units, were distributed into 20, equally wide intensity channels and the
percentages of total nuclei falling into each channel were plotted. The curves thus
obtained were integrated to calculate the average fluorescence intensity (AFI) of the
sample. In each experiment, the DNA content of the test nuclei was expressed as a
percentage of increase of their AFI over AFI of control nuclei (2n, non-reactivated
myotubes). γ-H2AX levels were similarly measured, except that reactivated nuclei
were detected by Ki67 immunofluorescence.
DNA combing assay. Exponentially growing myoblasts and rMt were subjected
to sequential pulses with two deoxythymidine analogs: 5-iodo-2′-deoxyuridine (IdU,
Sigma Aldrich) and 5-Chloro-2′-deoxyuridine (CldU, Sigma Aldrich), both at 100 μM
final concentration. The length of the pulses were: 30 min each for myoblasts and
deoxynucleoside-supplemented rMt; 60 min each for control rMt. Immediately
afterwards, cells were collected and immobilized into agarose plugs (100–200 000
cells/plug). Plugs were then incubated overnight in 2 mg/ml proteinase K solution
(1% N-laurosylsarcosine, 0.1 M EDTA pH 8, 0.01 M Tris-HCl pH 8, 0.02 M NaCl) and
DNA was released by incubation with three units of β-agarase (New England Biolabs,
Ipswich, MA, USA) in 0.1 M MES, pH 6.1. DNA stretching on silanised surfaces was
performed according to a validated procedure.21,24 Preparations were denatured in
1 M NaCl and 50 mM NaOH for 15 min before being incubated for 30 min with anti-
BrdU antibodies, cross-reacting, respectively, with IdU (Becton Dickinson, developed
in mouse, 2:7 dilution) and CldU (Abcam, developed in rat, 1:40 dilution). Slides were
then incubated for 30 min with a mixture of AlexaFluor 488-conjugated anti-mouse
IgG and AlexaFluor 594-conjugated anti-rat IgG (all from Life Technologies, 1:50
dilution). DNA was immunodetected by three successive incubations steps, using,
respectively, primary mouse IgG2A anti-ssDNA (Millipore, Clone 3034, 1:25 dilution,
90 min), AlexaFluor 350-conjugated anti-mouse IgG2A developed in goat, and
AlexaFluor 350-conjugated anti goat IgG developed in donkey (both secondary
antibodies from Life Technologies, 1:50 dilution, 30 min). In summary, DNA was
counterstained with blue fluorescence and replication forks are detected by green and
red fluorescences. A motorized fluorescence microscope (Zeiss Axio Imager.M1)
equipped with a CCD camera (Photometrix, Kew, Victoria, Australia, Coolsnap HQ2)
was used to score slides under a 40 × oil immersion objective (NA= 1.30). Adjacent
fields were acquired with the necessary filter sets. By aligning merged images (using
Adobe (San Jose, CA, USA) Photoshop CS2), whole DNA molecules were
reconstructed. Fluorescent patterns were measured by the Metavue Research Imaging
System (Molecular Devices, Sunnyvale, CA, USA), according to the molecular combing
calibration factor (1 μm= 2 kb) and the magnification provided by objective and CCD
camera (1 pixel= 0.16125 μm). The lengths of replication tracks and their spatial
organization define the replication profile (fork rate, inter-origin distances, initiation sites,
size of the replication clusters). Stringent criteria were applied to interpret the
fluorescent patterns. A detailed description can be found in Palumbo et al.24
Gene expression analysis by qPCR. Total RNA was isolated from cell
cultures with TRIzol reagent (ThermoFisher Scientific) and cDNA was synthesized
from 2 μg of RNA using the High Capaciy cDNA Reverse Transcription Kit (Applied
Biosystems, Foster City, CA, USA), according to the manufacturer’s instructions.
qPCR was performed with 0.3 μl of cDNA (from a 20-μl total reaction volume),
using SYBR Green cyanine dye (SensiMix, Bioline, Taunton, MA, USA), on a 7500
Fast Real-Time PCR System (Applied Biosystems). The specificity of qPCR
reactions was verified by the melting temperature method. Each gene was assayed
in triplicate and the mean threshold cycle (Ct) value was calculated. The Pctk1
housekeeping gene (hg), found to be homogeneously expressed in all samples, was
used to normalize target gene (tg) results. Proliferating myoblasts were used as
reference (Ctref). Gene expression fold-change was calculated as 2
−ΔΔCt, where
ΔΔCt= (Cttg−Cthg)− (Ctref−Cthg), setting to 1 the expression of tg in proliferating
myoblasts. The following primers were used: RNR-R1 (5′-CCCAATGAGTGT
CCTGGTCT-3′, 5′-GTTCTGCTGGTTGCTCTTCC-3′); RNR-R2 (5′-CCTACTAA
CCCCAGCGTTGA-3′, 5′-GTTTCAGAGCTTCCCAGTGC-3′); RNR-p53R2 (5′-
ACACACGCACACACCACCTGTA-3′, 5′-TGACAAATGGGAAGCACAGAGC-3′);
DCTD (5′-GAAGCAAGGACCCAAGTTTCC-3′, 5′-CCTTCACATCAGCCGAGTTCT
-3′); TS (5′-ATGTGGTGAATGGGGAACTGT-3′, 5′-GAGCTTTGGGAAAGGTCTT
GG-3′); TK1 (5′-CGATGTGACCCAGGAGTCC-3′, 5′-GGAGAGTGTGGTGAAGCT
CA-3′); TK2 (5′-TGTCCTTGTGTGAGAGAGCAGT-3′, 5′-CTCCAGGGTATACGGT
CATCAT-3′); dGK (QuantiTect primer assay, Qiagen); and Pctk1 (5′-ACT
GGAGACCTACATCAAGC-3′, 5′-GGATAGCAGTACAGGGTG-3′).
Thymidine kinase enzymatic assay. Cultures of exponentially growing
myoblasts and myotubes were rinsed three times with ice-cold 0.9% NaCl, drained,
and collected by scraping in ice-cold lysis buffer (10 mM Tri-HCl, pH 7.5, 0.5% Triton
X-100, 2 mM EDTA, 1 mM DTT), supplemented with 0.2 M NaCl and protease
inhibitors. Lysates were then centrifuged (16 000 × g at 4 °C for 30 min) and the
supernatant was aliquoted and stored at − 80 °C. Protein concentration was
determined by the Bradford colorimetric assay. TK activity was assayed as described in
Franzolin et al.38 The substrate was 1 μM [3H]TdR (Perkin-Elmer Life Sciences,
Waltham, MA, USA) (800 cpm/pmol) and two different aliquots of extracts were used to
check for proportionality of the assay. We expressed TK activity as pmol product/min/
mg protein.
Chromatin immunoprecipitation. ChIP experiments were performed as
previously described.39 In particular, crosslinking was performed by treating cell
cultures with 1% formaldehyde, for 10 min, at 22 °C; the reaction was stopped by
adding glycine to a final concentration of 0.125 M. Cells were then washed,
collected by scraping in PBS, centrifuged, and lysing the cytoplasms with ChIP lysis
buffer (5 mM Pipes, 85 mM KCl, 0.5% NP-40). The nuclei thus isolated were
resuspended in ChIP sonication buffer (1% SDS, 10 mM EDTA, 50 mM Tris HCl, pH
8) and optimal chromatin fragmentation (size: 0.3–1 Kb) was empirically obtained.
Chromatin (30–50 μg/ChIP) was then diluted in ChIP dilution buffer (0.01% SDS,
1.2 mM EDTA, 16.7 mM Tris HCl, pH8, 1.1% Triton X-100, 167 mM NaCl),
precleared with Protein A/G Plus Agarose beads (Pierce, Waltham, MA, USA), and
incubated for 3 h with Protein A/G Plus Agarose/antibody beads. ChIP buffers were
all supplemented with complete protease inhibitors (Roche). The immunoprecipi-
tated chromatin was then washed seven times with buffer A (0.1% SDS, 2 mM
EDTA, 20 mM Tris HCl, pH8, 1% Triton X-100, 150 mM NaCl) and seven times with
buffer B (same as buffer A, but with 500 mM NaCl). To increase specificity, one
wash with buffer C (1 mM EDTA, 10 mM Tris HCl, pH8, 250 mM LiCl, 1% NP-40,
1% Na-deoxycholate) was performed. DNA fragments were then eluted by
incubating the beads with ChIP elution buffer (1% SDS, 100 mM NaHCO3) twice for
15 min. Crosslink reversion, proteinase K digestion, and DNA precipitation were
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performed according to a previously described protocol.39 Input DNAs was
subjected to nonspecific-IgG ChIP. The following rabbit polyclonal antibodies were
used at 4 μg/ChIP: H3K9ac (Millipore cat. no. 06-942); RNA polymerase II (N-20,
Santa Cruz); RNA polymerase II phosphorylated on CTD-Ser5 (ab5131, Abcam);
non-immune rabbit IgG (Bioscience, East Rutherford, NJ, USA). qPCR was
performed on immunoprecipitated DNA fragments as described above and the
comparative threshold (ΔCt) method was used to determine the relative proportions
of specifically immunoprecipitated fragments in different samples.40 Briefly, the ΔCt
value was calculated for each sample (S) and for control IgG (C) by subtracting the
Ct value of S or C from the Ct value of the input (In). Relative enrichment was then
determined as follows: 2ΔCt(S)− 2ΔCt(C), where ΔCt(S)=Ct(In)−Ct(S) and ΔCt
(C)=Ct(In)−Ct(C). SYBR melting temperature curve and gel electrophoretic
analyses were performed to verify the specificity of each qPCR primer couple. For
each gene, primer sequences were designed to target the promoter near the
transcription start site. The following primers were used: Cyclin A2 (5′-
ACTCCGGACGCCCTCATT-3′, 5′-AGTTCAAGTAGCCCGCGACTAT-3′); Myogenin
(5′-TCACATGTAATCCACTGGAAACGT-3′, 5′-AAACCTGAGCCCCCCTCTAA-3′);
PAX7 (5′-AAGAGACGCCAAGAGGTTTATCC-3′, 5′-CGCACGCTGGAGACGAAT
-3′); and TK1 (5′-TGAGAGGTGGGACGAGTCTTG-3′, 5′-TGCCCGCGAACTCA
AAA-3′).
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